Wulff-Erik von Borcke

Director Ejecutivo en PHARMACYCLICS, INC. .

Health Technology

Perfil

Wulff-Erik von Borcke is currently the President & Chief Executive Officer at Pharmacyclics LLC since 2015.
Prior to this, he was the Chief Executive Officer at Abbott GmbH (Germany).

Cargos activos de Wulff-Erik von Borcke

Empresas	Cargo	Inicio
PHARMACYCLICS, INC.	Director Ejecutivo	01/05/2015

Todos los cargos activos de Wulff-Erik von Borcke

Antiguos cargos conocidos de Wulff-Erik von Borcke.

Empresas	Cargo	Fin
Abbott GmbH (Germany) Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany.	Director Ejecutivo	-

Ver el detalle de la experiencia de Wulff-Erik von Borcke.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wulff-Erik von Borcke.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Abbott GmbH (Germany) Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany.	Health Technology
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA.	Health Technology